Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.

E GómezJ L MonteroE MolinaL García-BueyM CasadoJ FuentesM A SimónA Díaz-GonzálezF JorqueraR M MorillasJ PresaM BerenguerM I CondeAntonio OlveiraG MacedoIsabel GarridoM Hernández-GuerraI OlivasSergio Rodríguez-TajesM LondoñoJ M SousaJ AmpueroE Romero-GonzálezSh González-PadillaD Escudero-GarcíaA CarvalhoA SantosM L GutiérrezE Pérez-FernándezL AburruzaJ UrizD GomesL SantosJ Martínez-GonzálezA AlbillosConrado M Fernández Rodríguez

Published in: Alimentary pharmacology & therapeutics (2024)

Triple therapy was superior in achieving therapeutic goals in UDCA-nonresponsive PBC. Decompensation was linked to pre-existing portal hypertension.

Keyphrases

blood pressure
primary care
healthcare
cross sectional
adipose tissue
bone marrow
quality improvement
skeletal muscle
cell therapy
arterial hypertension